Money really does talk. Some health plans pay beneficiaries anywhere from $10 to $150 or more to pick low-cost hospitals, imaging centers, infusion sites, clinical laboratories, and other care providers. It seems to be a win-win. The more insurers save, the more financial incentives they give out.
When the relentless climb in health care spending began to level off in 2002, few experts predicted that we may have turned a corner because economists, to this day, can’t agree on what caused the downturn. Not only does the deceleration continue, but we may eventually talk of decreasing costs.
CMS now pays for developing a care management plan for patients with chronic conditions. When it comes to compliance with regulations governing payment, however, providers are long on uncertainty and CMS is short on guidance. Problems with EHRs and costs to the patient may compromise the regulation’s effectiveness.
Faster care provided to people who overdose on opioid analgesics by a new naloxone autoinjector could cancel out the costs for the devices, according to researchers. Evzio does not require medical training to use and can therefore be administered by laypeople.